Characterization of Hepatitis B virus molecular genotypes in chongqing and quantitative serological markers in patients during natural phases of chronic Hepatitis B infection

Intervirology

Volumn 55, Issue 1, 2011, Pages 68-72

  Xiang, Yu ^a   Huang, Shifeng ^a   Xia, Jirong ^a   Ye, Diqing ^a   Chen, Pu ^a   Zhang, Liping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Epidemiology; Hepatitis B infection; Hepatitis B virus genotype; Quantitative immunoassays

Indexed keywords

ARTICLE; CHEMOLUMINESCENCE; CHINA; GENOTYPE; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CHILD; CHINA; FEMALE; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 80855156684     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000323524     Document Type: Article

References (13)

1. Kao JH, Chen DS: Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395-403.
2. McMahon BJ: The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49:S45-S55.
3. Bowden DS, Thompson AJ: New developments in HBV molecular diagnostics and quantitative serology. Hepatol Int 2008; 2:S3-S11. (Pubitemid 351593897)
4. Feld JJ, Wong DKH, Heathcote EJ: Endpoints of therapy in chronic hepatitis B. Hepatology 2009; 49:S96-S102.
5. Liu CJ, Kao JH, Chen DS: Therapeutic impli-c at ions of hepatitis B virus genotypes. Liver Int 2005;25:1097-1107.
6. Jin H, Wang J, Yan L, Nie JJ, Li J, Zhuang H: Establishment of a nested PCR to identify hepatitis B virus genotypes A-D and sub-genotypes B1, B2, C1 and C2. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29:1235-1239.
7. Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, Negus SE, McMahon BJ: Clearance of hepatitis Beantigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroen-terology 2007; 133: 1452-1457. (Pubitemid 350029740)
8. Liu CJ, Kao JH: Hepatitis B genotype: what should the clinician know? Curr Hepatitis Rep 2007; 6:17-23.
9. Maeshiro T, Arakaki S, Watanabe T, Aoyama H, Shiroma J, Yamashiro T, Hirata T, Hokama A, Kinjo F, Nakayoshi T, Nakayoshi T, Mizokami M, Fujita J, Sakugawa H: Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life. World J Gastroenterol 2007; 13: 4560-4565. (Pubitemid 47455233)
10. Chu CM, Liaw YF: Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 2007; 133: 1458-1465.
11. Chu CM, Liaw YF: Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol 2005; 43:411-417.
12. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Corn-berg M: Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010; 52: 514-522.
13. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA: Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010;52: 508-513.